Skip to content

Weyburn has no new COVID cases, only one active case left

There are 113 new cases of COVID-19 to report in Saskatchewan on May 31, bringing the provincial total to 46,748 cases, with no new COVID cases in the Weyburn area.
coronavirus

There are 113 new cases of COVID-19 to report in Saskatchewan on May 31, bringing the provincial total to 46,748 cases, with no new COVID cases in the Weyburn area. The number of active cases in the Weyburn area is now down to one, with 103 active cases in the southeast region as a whole.

One new death was reported in the 80+ age group from the Saskatoon zone.

The new cases are located in the following zones: Far North West, 6; Northwest, 10; North Central, 9; Northeast, 1; Saskatoon, 24; Central East, 8; Regina, 24; Southwest, 5; South Central, 15; and Southeast, 9. Two new cases are pending residence information. Two cases with pending residence information have been assigned to the North Central zone.

Recoveries total 44,841, including 174 new recoveries as of May 31, and 1,368 cases are considered active.

There are 108 people in hospital, the lowest total in hospital since November 28, 2020. Eighty-three people are receiving inpatient care: Northwest, 5; North Central, 5; Northeast, 2; Saskatoon, 32; Central East, 3; Regina, 32; Southwest, 2; South Central, 1; and Southeast, 1. Twenty-five people are in intensive care: Northwest, 1; North Central, 4; Saskatoon, 11; Central East, 1; and Regina, 8.

The seven-day average of new COVID-19 case number is 138 (11.3 per 100,000).

There were 1,748 COVID-19 tests processed in Saskatchewan on May 30, including 90 tests in the southeast region.

Step One of Saskatchewan's Re-Opening Roadmap is Now Underway

Thanks to the rapid expansion and delivery of COVID-19 vaccine and the patient and cautious following of public health measures by the public, the province was able to move forward with Step One of Saskatchewan's Re-Opening Roadmap.

Public health orders have been updated and details on the Re-Opening Roadmap can be viewed at https://www.saskatchewan.ca/government/health-care-administration-and-provider-resources/treatment-procedures-and-guidelines/emerging-public-health-issues/2019-novel-coronavirus/saskatchewans-re-opening-roadmap.

While the restrictions being lifted are no longer mandatory, many are still recommended. Only increase your contact with others as much as you feel comfortable. Older persons and those with increased risk factors may wish to wait until two weeks after receiving a second dose before attending gatherings. Transmission is generally less likely outdoors than indoors.

Step Two of Saskatchewan's Re-Opening Roadmap is tentatively scheduled to begin on June 20. If we continue to remain diligent and observe public health measures, we will reach our goal of re-opening our province in the coming weeks.

An additional 8,039 doses of COVID-19 vaccine have been given in Saskatchewan, including 475 doses in the southeast region, bringing the total number of vaccines administered in the province to 725,648.

Seventy-seven per cent of those over the age of 40 have received their first dose, 71 per cent of those 30+ have received their first dose, and 66 per cent of those 18+ have received their first dose.

Second dose vaccinations are open to residents 70+ or anyone who received their first dose before March 15, 2021. Individuals diagnosed with or being treated for cancer and those who have received solid organ transplants will receive a letter of eligibility in the mail that will allow them priority access to a second dose. 

At this time AstraZeneca is only available for second doses for individuals who received AstraZeneca for their first dose and who are over the age of 85 or cancer patients, solid organ transplant patients, or patients receiving treatment with Rituximab and Ocrelizumab, who received a letter. These individuals will be contacted for an appointment.

Guidance on the administration of AstraZeneca second doses for the general population will be provided prior to the recommended 12-week interval between doses, which begins the second week of June.